Gust
OCTOBER 16, 2012
This summer I conducted our third annual survey of the pre-money valuation of pre-revenue companies recently funded by angel groups in North America. Access to our 2010 and 2011 surveys can be found at 2011 Valuation Survey of North American Angel Investor Groups. Pre-revenue life Science, biotech and medical device deals.
Tim Keane
JANUARY 12, 2010
« Power of Angel Investing in Milwaukee | Main. Term-sheets and Valuations: Thinking about Negotiations. The Valuation Question. When companies seeking their first round of serious funding are good enough to receive a term-sheet from an investor, the first issue that always arises is valuation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Gust
OCTOBER 12, 2011
During the summer of 2010, I developed a workshop, A New ACEF Valuation Workshop for Angels and Entrepreneurs. To provide some reference points, I surveyed thirteen angels groups in North American to determine their recent experience in negotiating the pre-money valuation of pre-revenue companies. Current Average. up slightly.
YoungUpstarts
SEPTEMBER 27, 2013
Quoting an inflated valuation. . When your valuation is too high, investors think you are either greedy or you don’t know what you are doing. In both cases, a high valuation can end a conversation. If you’ve accomplished very little and are still a few years away from revenue, VCs aren’t going to invest in your deal.
Tim Keane
AUGUST 20, 2009
from the August 20th Milwaukee Journal Sentinel. " The problem has been that too-high valuations and too generous terms have spawned painful down rounds that squash the entrepreneur and his early investors. up to $10MM in revenue. from the August 20th Milwaukee Journal Sentinel.
Expert insights. Personalized for you.
169 
Let's personalize your content